The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Germline alterations other than BRCA in triple negative breast cancer (TNBC) patients who underwent neoadjuvant therapy (NAT) on a prospective clinical trial.
 
Banu Arun
Consulting or Advisory Role - Abbvie; Bright Pink
Research Funding - Abbvie (Inst); AstraZeneca (Inst); InVitae (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Li Zhao
No Relationships to Disclose
 
Roland L. Bassett
No Relationships to Disclose
 
Alastair Mark Thompson
Honoraria - Novartis (I); Pfizer
Travel, Accommodations, Expenses - Novartis (I); Pfizer
 
Jason B White
Employment - AstraZeneca/MedImmune
Patents, Royalties, Other Intellectual Property - Two patents pending at AstraZeneca/Medimmune related to antibody-drug conjugate technology.
 
Rachel M. Layman
Consulting or Advisory Role - GE Healthcare (I); Genomic Health; Novartis; Pfizer; Siemens (I)
Research Funding - GlaxoSmithKline (Inst); Ipsen; Lilly; Novartis (Inst); Pfizer (Inst); Zentalis
 
Angelica Gutierrez Barrera
No Relationships to Disclose
 
Vicente Valero
Honoraria - Genentech/Roche
Consulting or Advisory Role - Genentech/Roche
Travel, Accommodations, Expenses - Genentech/Roche
 
Naoto T. Ueno
Honoraria - Amgen; Chugai/Roche; Eisai; Henry Stewart Talks; Kyowa Hakko Kirin; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Daiichi Sankyo; Immunomedics; Samsung Bioepis
Research Funding - Amgen; Bayer; Bio-Path Holdings; Celgene; Daiichi Sankyo; GlaxoSmithKline; Kyowa Hakko Kirin; Medivation; Merck; Novartis; Puma Biotechnology; Sysmex
Travel, Accommodations, Expenses - Kyowa Hakko Kirin
 
Jennifer Keating Litton
Honoraria - UpToDate
Consulting or Advisory Role - AstraZeneca; Ayala Pharmaceuticals; Medivation/Pfizer; Pfizer
Speakers' Bureau - Clinical Care Options; Med Learning Group; Medpage; Medscape; Physicans' Education Resource; Prime Oncology; UpToDate
Research Funding - AstraZeneca (Inst); EMD Serono (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Medivation/Pfizer (Inst); Novartis (Inst); pfizer (Inst); Zenith Epigenetics (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
Travel, Accommodations, Expenses - Clinical Care Options; Med Learning Group; Medscape; Physicans' Education Resource
Other Relationship - Medivation/Pfizer
 
Jianhua Zhang
No Relationships to Disclose
 
Elizabeth Ravenberg
No Relationships to Disclose
 
Rosalind P Candelaria
No Relationships to Disclose
 
Gaiane M Rauch
No Relationships to Disclose
 
Debu Tripathy
Consulting or Advisory Role - Genomic Health; GlaxoSmithKline; Nektar; Novartis; Pfizer; Polyphor; Sellas Life Sciences
Research Funding - Novartis (Inst); Polyphor (Inst)
Travel, Accommodations, Expenses - Novartis
 
Stacy L. Moulder
Research Funding - Bayer (Inst); EMD Serono (Inst); Genentech (Inst); Genentech (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Takeda (Inst)